Mkts

CRISPR Therapeutics AG

NASDAQ: CRSP
$38.93-1.26 (-3.14%)
As of Nov 19, 4:00 PM ET

Key statistics

Day range
38.3741.70
52-week range
39.8063.45
Today
Open40.49
Previous close38.93
Volume891.1K
Valuation
Market cap4.08B
P/E ratio—
EPS (TTM)-4.75
Income & risk
Dividend / yield—
Beta2.02
Avg volume1.66M
Discussion

CRSP News

Stories mentioning CRSP from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue1,458864.00889.00892.00865.0035,691602.00517.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development68,57483,52658,90269,89472,48471,73982,16080,165
Sales General & Admin
Total Operating Expenses131,706155,628132,948230,216149,289100,280110,732151,777
Operating Income (Loss)(130,248)(154,764)(132,059)(229,324)(148,424)(64,589)(110,130)(151,260)
Interest Income
Interest Expense
Other Expense8,15624,76526,23722,06713,53727,97825,06426,139
Pretax Income(122,092)(129,999)(105,822)(207,257)(134,887)(36,611)(85,066)(125,121)
Tax Provision839.00614.00619.001,2921,109700.00876.001,287
Net Income (Loss)(122,931)(130,613)(106,441)(208,549)(135,996)(37,311)(85,942)(126,408)
Earnings Per Share (Basic)(1.28)(1.45)(1.17)(2.40)(1.58)(0.44)(1.01)(1.49)
Earnings Per Share (Diluted)(1.28)(1.45)(1.17)(2.40)(1.58)(0.44)(1.01)(1.49)
Weighted Average Shares Outstanding (Basic)96,05189,92591,30587,07085,93984,35985,23584,921
Weighted Average Shares Outstanding (Diluted)96,05189,92591,30587,07085,93984,35985,23584,921

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CRSP

CRISPR Therapeutics AG (NASDAQ: CRSP) is a stock listed on the Nasdaq Stock Market under the ticker symbol CRSP. It last traded at $38.93 (Nov 19, 2026, 4:00 PM ET), down 3.1% on the day. That gives CRISPR Therapeutics a market capitalisation of $4.1B.

Over the past 52 weeks CRSP has traded between $39.80 and $63.45.

Revenue for the quarter ended Mar 31, 2026 was $1.5M; a net loss of $122.9M. Revenue was up 68.6% from $865.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$1.5M-$122.9M-8431.5%
Dec 31, 2025$864.0K-$130.6M-15117.2%
Sep 30, 2025$889.0K-$106.4M-11973.1%
Jun 30, 2025$892.0K-$208.5M-23379.9%

From CRISPR Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…